Status:
COMPLETED
Patient Outcomes and Gingival Blood Flow Using Laser Doppler Flowmetry Following the Use of Episil on Free Gingival Graft Donor Sites
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Pain From Free Gingival Graft
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The hypothesis for the present study is that patient-based outcomes and gingival blood flow will be more favorable for the free gingival graft (FGG) donor sites being covered by the test wound dressin...
Eligibility Criteria
Inclusion
- patient of record at UTHealth School of Dentistry Houston Texas
- signed treatment plan for a FGG
- the ability to provide research informed consent
Exclusion
- any allergies to any of the ingredients in episil including allergies to peanuts, soy or peppermint oil
- smokers
- pregnant or breast feeding women
- inability or unwillingness to provide informed consent
Key Trial Info
Start Date :
October 29 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 19 2017
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03350724
Start Date
October 29 2015
End Date
May 19 2017
Last Update
April 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030